Semaglutide for the Treatment of Obesity in Children 6 to <12 Years of Age
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: New England Journal of Medicine
Institutions: Yale University, Novo Nordisk (Denmark), Helmholtz Munich, University Hospital Leipzig, Leipzig University, University of Minnesota, Paracelsus Medical University, University of Copenhagen, Holbæk Sygehus, Novo Nordisk Foundation Center for Basic Metabolic Research, Novo Nordisk (India), Universität Ulm, University Hospital Ulm
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Novo Nordisk
OpenAlex ID: W7234565486
